Adverum Biotechnologies
ADVM
ADVM
116 hedge funds and large institutions have $693M invested in Adverum Biotechnologies in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 13 closing their positions.
Holders
116
Holders Change
+17
Holders Change %
+17.17%
% of All Funds
2.29%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
%
% of All Funds
0.12%
New
31
Increased
33
Reduced
38
Closed
13
Calls
$13.5M
Puts
$3.69M
Net Calls
+$9.85M
Net Calls Change
+$9.28M
Top Buyers
| 1 |
ACP
1
Acuta Capital Partners
Redwood City,
California
|
$15.2M |
| 2 |
ACA
2
Avoro Capital Advisors
New York
|
$60.5M |
| 3 |
VMI
3
VHCP Management III
New York
|
$10.9M |
| 4 |
4
Goldman Sachs
New York
|
$13.2M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$32.4M |
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$36M |
| 2 |
2
Renaissance Technologies
New York
|
$16.8M |
| 3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$1.14M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$3.04M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$13.5M |
